Gannon Steven
CIK 0001643085
Director
Filings
11
Latest Jun 3, 2026
Issuers covered
2
Showing
11 of 11
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 80% | +5.4% | +7.7% | +7.7% | -3.6% |
| 90 days | 5 | 80% | +8.6% | +17.3% | +17.3% | -26.4% |
| 180 days | 5 | 80% | +2.5% | +13.0% | +13.0% | -39.5% |
| 365 days | 4 | 100% | +20.9% | +20.9% | +20.9% | +20.9% |
Issuers
Companies where Gannon Steven has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 8 | Jun 3, 2026 |
| FUSN | Fusion Pharmaceuticals Inc. | 3 | Jun 4, 2024 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|